Remote Participation (Within USA) Trial of Sana Pain Reliever

NACompletedINTERVENTIONAL
Enrollment

75

Participants

Timeline

Start Date

January 16, 2020

Primary Completion Date

February 21, 2023

Study Completion Date

February 21, 2023

Conditions
Neuropathic PainChronic PainPain
Interventions
DEVICE

Sana Pain Reliever

Participants will receive the SPR device and a tablet with instructions of how to use the device and how to answer the questionnaires on the tablet mobile application. Each session with the device will last 16 minutes and run under the device's normal settings. The session consists of periods of light and sounds (beeps). Participants will be instructed to use the device each day at the end of the day prior to going to sleep and whenever they experience heightened pain during the day.

DEVICE

Sham SPR

Participants will receive the SPR device and a tablet with instructions of how to use the device and how to answer the questionnaires on the tablet mobile application. Each session with the device will last 16 minutes and run under the device's sham settings. The session consists of periods of light and sounds (beeps). Participants will be instructed to use the device each day at the end of the day prior to going to sleep and whenever they experience heightened pain during the day.

Trial Locations (1)

10011

Icahn School of Medicine at Mount Sinai, New York

All Listed Sponsors
collaborator

Sana Health, Inc.

UNKNOWN

lead

Icahn School of Medicine at Mount Sinai

OTHER

NCT04280562 - Remote Participation (Within USA) Trial of Sana Pain Reliever | Biotech Hunter | Biotech Hunter